{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:08:57Z","timestamp":1790698137904,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.canlet.2008.11.031","type":"journal-article","created":{"date-parts":[[2009,1,13]],"date-time":"2009-01-13T09:35:20Z","timestamp":1231839320000},"page":"91-100","source":"Crossref","is-referenced-by-count":77,"title":["Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest"],"prefix":"10.1016","volume":"277","author":[{"given":"T.L.","family":"Lam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.K.Y.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.C.","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.N.M.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.C.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.L.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.Y.","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.T.P.","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.N.","family":"Wheatley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.H.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.C.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2008.11.031_bib1","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1067\/msg.2002.122810","article-title":"Advances in the treatment of liver tumors","volume":"39","author":"Curley","year":"2002","journal-title":"Curr. Prob. Surg."},{"issue":"Suppl. 3","key":"10.1016\/j.canlet.2008.11.031_bib2","first-page":"iii1","article-title":"Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults","volume":"52","author":"Ryder","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2008.11.031_bib3","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1053\/j.semnuclmed.2007.10.004","article-title":"Natural history of hepatocellular carcinoma and current treatment options","volume":"38","author":"Raoul","year":"2008","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.canlet.2008.11.031_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0305-7372(02)00123-8","article-title":"Treatment of hepatocellular carcinoma: is there an optimal strategy?","volume":"29","author":"Varela","year":"2003","journal-title":"Cancer. Treat. Rev."},{"key":"10.1016\/j.canlet.2008.11.031_bib5","doi-asserted-by":"crossref","first-page":"7660","DOI":"10.1200\/JCO.2005.02.0933","article-title":"Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies","volume":"23","author":"Ascierto","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2008.11.031_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1158\/0008-5472.CAN-06-1945","article-title":"Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion","volume":"67","author":"Cheng","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.11.031_bib7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/bjc.1979.112","article-title":"Microenvironmental arginine depletion by macrophages in vivo","volume":"39","author":"Currie","year":"1979","journal-title":"Brit. J. Cancer"},{"key":"10.1016\/j.canlet.2008.11.031_bib8","first-page":"2932","article-title":"Effect of dietary arginine restriction upon ornithine and polyamine metabolism during two-stage epidermal carcinogenesis in the mouse","volume":"51","author":"Gonzalez","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.11.031_bib9","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1200\/JCO.2004.11.120","article-title":"Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I\/II studies","volume":"22","author":"Izzo","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2008.11.031_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev.nutr.22.110801.140547","article-title":"Regulation of enzymes of the urea cycle and arginine metabolism","volume":"22","author":"Morris","year":"2002","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.canlet.2008.11.031_bib11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/bjc.1974.112","article-title":"The effects of arginine deficiency on lymphoma cells","volume":"30","author":"Storr","year":"1974","journal-title":"Brit. J. Cancer"},{"key":"10.1016\/j.canlet.2008.11.031_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00008390-199209000-00007","article-title":"High sensitivity of human melanoma cell lines to the growth inhibitory activity of mycoplasmal arginine deiminase in vitro","volume":"2","author":"Sugimura","year":"1992","journal-title":"Melanoma Res."},{"key":"10.1016\/j.canlet.2008.11.031_bib13","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1349-7006.1995.tb03094.x","article-title":"Anti-tumor activity of arginine deiminase from Mycoplasma argini and its growth-inhibitory mechanism","volume":"86","author":"Takaku","year":"1995","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.canlet.2008.11.031_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.canlet.2004.10.050","article-title":"Remission of hepatocellular carcinoma with arginine depletion induced by systemic release of endogenous hepatic arginase due to transhepatic arterial embolisation, augmented by high-dose insulin: arginase as a potential drug candidate for hepatocellular carcinoma","volume":"224","author":"Cheng","year":"2005","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2008.11.031_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2007.11.038","article-title":"Arginine deiminase, a potential anti-tumor drug","volume":"261","author":"Ni","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2008.11.031_bib16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S030-43835(02)00693-6","article-title":"Resistance to the anti-proliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase","volume":"191","author":"Shen","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2008.11.031_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1006\/bbrc.1999.1004","article-title":"Arginine deiminase inhibits cell proliferation by arresting cell cycle and inducing apoptosis","volume":"261","author":"Gong","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2008.11.031_bib18","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/sj.leu.2401763","article-title":"Arginine deiminase inhibits proliferation of human leukemia cells more potently than asparaginase by inducing cell cycle arrest and apoptosis","volume":"14","author":"Gong","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2008.11.031_bib19","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/ijc.20435","article-title":"Arginine deiminase enhances dexamethasone-induced cytotoxicity in human T-lymphoblastic leukemia CCRF-CEM cells","volume":"112","author":"Noh","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2008.11.031_bib20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF03033696","article-title":"Arginine catabolism, liver extracts and cancer","volume":"8","author":"Wheatley","year":"2002","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.canlet.2008.11.031_bib21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1357-2725(96)00178-1","article-title":"Regulation of CDK\/cyclin complexes during the cell cycle","volume":"29","author":"Arellano","year":"1997","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.canlet.2008.11.031_bib22","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1126\/science.7997877","article-title":"Cell cycle control and cancer","volume":"266","author":"Hartwell","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.canlet.2008.11.031_bib23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/374131a0","article-title":"Principles of CDK regulation","volume":"374","author":"Morgan","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2008.11.031_bib24","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1073\/pnas.71.4.1286","article-title":"A restriction point for control of normal animal cell proliferation","volume":"71","author":"Pardee","year":"1974","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2008.11.031_bib25","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1126\/science.2683075","article-title":"G1 events and regulation of cell proliferation","volume":"246","author":"Pardee","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.canlet.2008.11.031_bib26","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjc.6600681","article-title":"Arginine deprivation, growth inhibition and tumour cell death: 2. Enzymatic degradation of arginine in normal and malignant cell cultures","volume":"88","author":"Philip","year":"2003","journal-title":"Brit. J. Cancer"},{"key":"10.1016\/j.canlet.2008.11.031_bib27","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1054\/bjoc.2000.1353","article-title":"Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells","volume":"83","author":"Scott","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2008.11.031_bib28","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/ijc.23723","article-title":"Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase","volume":"123","author":"Bowles","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2008.11.031_bib29","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/ijc.22322","article-title":"Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase","volume":"120","author":"Yoon","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2008.11.031_bib30","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0145-2126(90)90184-B","article-title":"Elevated argininosuccinate synthetase activity in adult T leukemia cell lines","volume":"14","author":"Sugimura","year":"1990","journal-title":"Leukemia Res."},{"key":"10.1016\/j.canlet.2008.11.031_bib31","first-page":"5443","article-title":"Pegylated arginine deiminase (ADI-SS PEG20,000mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo","volume":"62","author":"Ensor","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.11.031_bib32","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1517\/13543784.15.7.815","article-title":"Pegylated arginine deiminase: a novel anticancer enzyme agent","volume":"15","author":"Feun","year":"2006","journal-title":"Expert Opin. Investig Drugs"},{"key":"10.1016\/j.canlet.2008.11.031_bib33","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1006\/excr.1999.4779","article-title":"Single amino acid (arginine) deprivation induces G1 arrest associated with inhibition of cdk4 expression in cultured human diploid fibroblasts","volume":"255","author":"Lamb","year":"2000","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.canlet.2008.11.031_bib34","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1083\/jcb.75.3.881","article-title":"Arginine deprivation in KB cells. I. Effect on cell cycle progress","volume":"75","author":"Weissfeld","year":"1977","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.canlet.2008.11.031_bib35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000016333","article-title":"Single amino acid (arginine) restriction: growth and death of cultured HeLa and human diploid fibroblasts","volume":"10","author":"Wheatley","year":"2000","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.canlet.2008.11.031_bib36","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","article-title":"Cancer cell cycles","volume":"274","author":"Sherr","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.canlet.2008.11.031_bib37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0968-0004(00)89005-2","article-title":"D-type cyclins","volume":"20","author":"Sherr","year":"1995","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.canlet.2008.11.031_bib38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4161\/cc.1.1.106","article-title":"D1 in G2","volume":"1","author":"Sherr","year":"2002","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2008.11.031_bib39","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0955-0674(03)00008-5","article-title":"Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells","volume":"15","author":"Stacey","year":"2003","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.canlet.2008.11.031_bib40","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/jn\/131.8.2197","article-title":"Downregulation of the cyclin D1\/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines","volume":"131","author":"Wolter","year":"2001","journal-title":"J. Nutr."},{"key":"10.1016\/j.canlet.2008.11.031_bib41","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1073\/pnas.87.5.1973","article-title":"Abnormal structure and expression of p53 gene in human hepatocellular carcinoma","volume":"87","author":"Bressac","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2008.11.031_bib42","first-page":"22","article-title":"Tumour suppressor p53 and Rb genes in human hepatocellular carcinoma","volume":"25","author":"Lin","year":"1996","journal-title":"Ann. Acad. Med. Singapore"},{"key":"10.1016\/j.canlet.2008.11.031_bib43","first-page":"3356","article-title":"Detection of aberrations of the p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis","volume":"51","author":"Murakami","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.11.031_bib44","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.6248960","article-title":"Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen","volume":"209","author":"Knowles","year":"1980","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.canlet.2008.11.031_bib45","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1099\/0022-1317-64-10-2299","article-title":"Defective hepatitis B virus DNA molecules detected in a stable integration pattern in a hepatoma cell line, and in induced tumours and derived cell lines","volume":"64","author":"Monjardino","year":"1983","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.canlet.2008.11.031_bib46","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ceb.2005.09.009","article-title":"Growing roles for the mTOR pathway","volume":"17","author":"Sarbassov","year":"2005","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.canlet.2008.11.031_bib47","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/emboj.2008.39","article-title":"cdc2-Cyclin B regulates eEF2 kinase activity in a cell cycle- and amino acid-dependent manner","volume":"27","author":"Smith","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2008.11.031_bib48","series-title":"Pyrimidine and Purine Antimetabolites","author":"Holland","year":"1997"},{"key":"10.1016\/j.canlet.2008.11.031_bib49","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-Fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2008.11.031_bib50","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1172\/JCI6863","article-title":"Disruption of p53 in human cancer cells alters the responses to therapeutic agents","volume":"104","author":"Bunz","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2008.11.031_bib51","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bcp.2004.11.006","article-title":"Modulation of 5-fluorouracil cytotoxicity through thymidylate synthase and NF-kappaB down-regulation and its application on the radiolabelled iododeoxyuridine therapy on human hepatoma cell","volume":"69","author":"Wang","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2008.11.031_bib52","doi-asserted-by":"crossref","first-page":"7826","DOI":"10.1128\/MCB.20.20.7826-7837.2000","article-title":"A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs","volume":"20","author":"Eichhorst","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2008.11.031_bib53","first-page":"1253","article-title":"Combination of 5-FU and IFNalpha enhances IFN signaling pathway and caspase-8 activity, resulting in marked apoptosis in hepatoma cell lines","volume":"29","author":"Koike","year":"2006","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2008.11.031_bib54","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/1471-2407-6-232","article-title":"Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction","volume":"6","author":"Schulze-Bergkamen","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2008.11.031_bib55","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/hep.510290102","article-title":"Apoptosis in human hepatoma cell lines by chemotherapeutic drugs via Fas-dependent and Fas-independent pathways","volume":"29","author":"Jiang","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2008.11.031_bib56","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.biopha.2007.02.007","article-title":"Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance","volume":"61","author":"Brenes","year":"2007","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2008.11.031_bib57","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1046\/j.1365-2141.2003.04707.x","article-title":"Pegylated asparaginase in combination with high-dose methotrexate for consolidation in adult acute lymphoblastic leukaemia in first remission: a pilot study","volume":"123","author":"Rosen","year":"2003","journal-title":"Brit. J. Haematol."},{"key":"10.1016\/j.canlet.2008.11.031_bib58","first-page":"2583","article-title":"Anticancer efficacy in vivo and in vitro, synergy with 5-fluorouracil, and safety of recombinant methioninase","volume":"58","author":"Yoshioka","year":"1998","journal-title":"Cancer Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383508009117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383508009117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T05:57:09Z","timestamp":1558072629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383508009117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0304383508009117"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2008.11.031","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}